Keyphrases
Glioblastoma
100%
Gene Silencing
100%
Temozolomide
100%
MGMT Promoter
100%
MGMT Gene
100%
Radiotherapy
50%
Confidence Interval
50%
Tumor
33%
Log-rank Test
33%
Randomized Trial
16%
Median Survival
16%
Survival Benefit
16%
Methylation Status
16%
Methylation
16%
Patient Survival
16%
Adjuvant Therapy
16%
Prognostic Factors
16%
DNA Repair
16%
Long-term Survival
16%
Treatment Group
16%
Promoter Methylation
16%
Epigenetic Silencing
16%
Hazard Ratio
16%
Polymerase Chain Reaction Analysis
16%
Concomitant Treatment
16%
O6-methylguanine-DNA Methyltransferase
16%
P Factor
16%
Alkylating Agents
16%
DNA Repair Genes
16%
Radiotherapy Alone
16%
Methylation-specific Polymerase Chain Reaction
16%
MGMT Promoter Methylation
16%
Medicine and Dentistry
Promoter Region
100%
Glioblastoma
100%
Temozolomide
100%
Gene Inactivation
100%
Methylation
62%
Radiation Therapy
50%
Neoplasm
25%
Log Rank Test
25%
DNA Repair
25%
Adjuvant Therapy
12%
Hazard Ratio
12%
Prognostic Factor
12%
Alkylating Antineoplastic Agent
12%
Reaction Analysis
12%
Methylated DNA Protein Cysteine Methyltransferase
12%
Polymerase Chain Reaction
12%
Biochemistry, Genetics and Molecular Biology
Promoter Region
100%
Gene Inactivation
100%
Methylation
62%
DNA Repair
25%
Epigenetics
12%
DNA Methyltransferase
12%
Polymerase Chain Reaction
12%
6-O-Methylguanine
12%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Temozolomide
100%
Neoplasm
50%
Alkylating Agent
25%
Methylated DNA Protein Cysteine Methyltransferase
25%